<p>The implementation of AI technology revolutionized HNC personal medicine through improved drug prescriptions which led to superior patient results. Computational systems review multiple patient data points comprising genetic information together with medical pictures and medical record information to produce therapeutic outcome predictions and patient stratification. Strategic treatment plans can be generated specifically for each patient because of these algorithms which reflect their individual characteristics thus enhancing treatment effectiveness and minimizing negative effects. Machine learning models along with predictive analytics tools estimate drug reactions and toxicity levels to support data-based healthcare delivery decisions. By analyzing unstructured clinical data through natural language processing methods health professionals receive strategic insights for creating tailored patient treatments. Healthcare professionals utilize artificial intelligence systems with patient-driven data analytics to receive automated recommendations about the best available medicinal prescriptions and dosage variations. AI-optimized treatment strategies enhance the response rates and survival statistics for patients diagnosed with head and neck cancers according to clinical research. Precision medicine faces implementation hurdles from additional considerations about healthcare privacy and programmed discrimination and the requirement of superior medical infrastructure and qualified expertise. Wholehearted success of AI implementation in oncology depends on the resolution of emerging challenges through planned strategic connections and ethical standards. Developments in technology enable AI-based drug advancement which creates individualized therapies for HNC patients across all regions while improving cancer treatment methods worldwide.</p>